Lucio Crinò
- Oncology top 0.05%
- Lung Cancer Research Studies 125
- Colorectal Cancer Treatments and Studies 67
- Cancer Immunotherapy and Biomarkers 33
- HER2/EGFR in Cancer Research 27
- Pulmonary and Respiratory Medicine top 0.02%
- Lung Cancer Treatments and Mutations 252
- Lung Cancer Diagnosis and Treatment 65
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 50
- Hepatology top 1%
- Genetics top 0.5%
-
- Cancer therapeutics and mechanisms 37
- Co-authors
- Federico CappuzzoEnriqueta FelipVienna LudoviniGiulio MetroMaurizio TonatoGiorgio V. ScagliottiFilippo de MarinisStefania Bartolini
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Lucio Crinò
369 papers receiving 19.0k citations
Hit Papers
Peers
Comparison fields: 5 of 140
- Oncology 13.5k
- Pulmonary and Respiratory Medicine 13.4k
- Cancer Research 3.3k
- Hepatology 855
- Genetics 1.1k
Countries citing papers authored by Lucio Crinò
This map shows the geographic impact of Lucio Crinò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucio Crinò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucio Crinò more than expected).
Fields of papers citing papers by Lucio Crinò
This network shows the impact of papers produced by Lucio Crinò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucio Crinò. The network helps show where Lucio Crinò may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lucio Crinò, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2022 | 4 | |
| 6 | 2021 | 0 | |
| 7 | 2017 | 8 | |
| 8 | 2017 | 8 | |
| 9 | 2016 | 196 | |
| 10 | 2015 | 52 | |
| 11 | 2013 | 40 | |
| 12 | Identification of Targetable Driver Mutations In Molecularly Selected Never Smoker Lung Adenocarcinomas | 2013 | 1 |
| 13 | Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2013 | 458 |
| 14 | 2011 | 13 | |
| 15 | Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upbreakdown → | 2010 | 424 |
| 16 | 2010 | 120 | |
| 17 | 2007 | 174 | |
| 18 | 2004 | 37 | |
| 19 | 2003 | 175 | |
| 20 | 2002 | 2 |
About Lucio Crinò
Lucio Crinò is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 372 papers that have together received 19.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (252 papers), Lung Cancer Research Studies (125 papers), Colorectal Cancer Treatments and Studies (67 papers), Lung Cancer Diagnosis and Treatment (65 papers), Cancer Genomics and Diagnostics (50 papers), Cancer therapeutics and mechanisms (37 papers), Cancer Immunotherapy and Biomarkers (33 papers) and HER2/EGFR in Cancer Research (27 papers). The work is most often cited by research in Oncology (13.5k citations), Pulmonary and Respiratory Medicine (13.4k citations) and Cancer Research (3.3k citations). Lucio Crinò has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Federico Cappuzzo, Enriqueta Felip, Vienna Ludovini, Giulio Metro, Maurizio Tonato, Giorgio V. Scagliotti, Filippo de Marinis, Stefania Bartolini, Alice T. Shaw and Pasi A. Jänne. Their work appears in journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.